Clinical Trial Update: Role of Topical Putrescine (Fibrostat) for Prevention of Hypertrophic Scars in Mammoplasty Patients [Phase 3]

View source ↗

Summary

Phase 3 trial investigating topical putrescine (Fibrostat) to prevent hypertrophic scars in mammoplasty patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Scar

Drugs mentioned

• Fibrostat (putrescine)

Snippet

Sponsor: University of Manitoba | Conditions: Hypertrophic Scar | Phase 3 | Status: COMPLETED